J. Howell

发表

Comparison of macular parameters after femtosecond laser-assisted and conventional cataract surgery in age-related macular degeneration.

M. Thiel, L. Faes, M. Schmid, 2018, Journal of cataract and refractive surgery.

Blood flow velocity measured using the Retinal Function Imager predicts successful ranibizumab treatment in neovascular age-related macular degeneration: early prospective cohort study

M. Thiel, L. Faes, M. Schmid, 2015, Eye.

The Disc Damage Likelihood Scale (DDLS): Interobserver Agreement of a New Grading System to Assess Glaucomatous Optic Disc Damage

M. Thiel, F. Bochmann, J. Howell, 2009, Klinische Monatsblatter fur Augenheilkunde.

Novel CACNA1A mutation(s) associated with slow saccade velocities

R. Müri, Simon Jung, T. Nyffeler, 2013, Journal of Neurology.

Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series analysis

L. Faes, M. Schmid, L. Bachmann, 2015, BMC Ophthalmology.

Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life

M. Thiel, L. Faes, M. Schmid, 2015, PloS one.

Risk Management and Healthcare Policy Dovepress Anti-vegf Treatment Patterns and Associated Health Care Costs in Switzerland: Findings Using Real-world Claims Data

M. Thiel, L. Faes, M. Schmid, 2022 .

Cyclodialysis Cleft after Intravitreal Injection of Ranibzumab – Diagnosis and Management

M. Schmid, F. Bochmann, J. Howell, 2015, Klinische Monatsblätter für Augenheilkunde.

Risk Management and Healthcare Policy Dovepress Anti-vegf Treatment Patterns and Associated Health Care Costs in Switzerland: Findings Using Real-world Claims Data

M. Thiel, L. Faes, M. Schmid, 2022 .

Risk Management and Healthcare Policy Dovepress Anti-vegf Treatment Patterns and Associated Health Care Costs in Switzerland: Findings Using Real-world Claims Data

M. Thiel, M. Schmid, M. Bittner, 2022 .

Risk Management and Healthcare Policy Dovepress Anti-vegf Treatment Patterns and Associated Health Care Costs in Switzerland: Findings Using Real-world Claims Data

M. Thiel, M. Schmid, M. Bittner, 2022 .

anti-VegF treatment patterns and associated health care costs in Switzerland: findings using real-world claims data

M. Thiel, M. Schmid, M. Bittner, 2015 .